#pmda — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #pmda, aggregated by home.social.
-
Why many global drugs never reach Japan
For years, Japan’s “drug lag” was shorthand for slow regulatory reviews and delayed approvals compared with the U.S. and Europe. But even as regulatory timelines have shortened, review capacity has expanded and international alignment has improved, Japanese patients still face gaps in a…
#Japan #JP #JapanNews #Asia--Pacific #BioWorld #drugdevelopment #druglag #news #PMDA #regulatory
https://www.alojapan.com/1447760/why-many-global-drugs-never-reach-japan/ -
https://www.alojapan.com/1447760/why-many-global-drugs-never-reach-japan/ Why many global drugs never reach Japan #AsiaPacific #BioWorld #DrugDevelopment #DrugLag #Japan #JapanNews #news #PMDA #regulatory For years, Japan’s “drug lag” was shorthand for slow regulatory reviews and delayed approvals compared with the U.S. and Europe. But even as regulatory timelines have shortened, review capacity has expanded and international alignment has improved, Japanese patients still face gaps in access to innovative drugs. B
-
DATE: October 15, 2025 at 06:30PM
SOURCE: BioWorld MedTechDirect article link at end of text block below.
#PMDA makes case for #Japan as a haven for innovation
Here are any URLs found in the article text:
Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech
-
DATE: October 15, 2025 at 06:30PM
SOURCE: BioWorld MedTechDirect article link at end of text block below.
#PMDA makes case for #Japan as a haven for innovation
Here are any URLs found in the article text:
Articles can be found by scrolling down the page at https://www.bioworld.com/topics/85-bioworld-medtech .
-------------------------------------------------
Private, vetted email list for mental health professionals: https://www.clinicians-exchange.org
.
NYU Information for Practice puts out 400-500 good quality health-related research posts per week but its too much for many people, so that bot is limited to just subscribers. You can read it or subscribe at @PsychResearchBot
.
Since 1991 The National Psychologist has focused on keeping practicing psychologists current with news, information and items of interest. Check them out for more free articles, resources, and subscription information: https://www.nationalpsychologist.com
.
EMAIL DAILY DIGEST OF RSS FEEDS -- SUBSCRIBE:
http://subscribe-article-digests.clinicians-exchange.org
.
READ ONLINE: http://read-the-rss-mega-archive.clinicians-exchange.org
.
It's primitive... but it works... mostly...
.
-------------------------------------------------#healthcare #healthtech #healthcaretech #healthtechnology #medgadget #medicine #doctor #hospital #medtech
-
https://www.alojapan.com/1377606/varmx-receives-phase-1-waiver-from-japanese-regulator-pmda/ VarmX receives Phase 1 waiver from Japanese regulator PMDA #biotech #DrugDevelopment #Japan #JapanNews #Japanese #JapaneseNews #news #Phase3 #PMDA #VarmXB.V. VarmX receives Phase 1 waiver from Japanese regulator PMDA for lead asset VMX-C001 Japanese regulator, the PMDA, waived the requirement for a Phase 1 trial in Japanese subjects for lead asset VMX-C001, enabling it to go straight to Phase 3 developmentRare waiver recognizes the global dat
-
VarmX receives Phase 1 waiver from Japanese regulator PMDA
VarmX receives Phase 1 waiver from Japanese regulator PMDA for lead asset VMX-C001 Japanese regulator, the PMDA, waived the requirement for a Phase 1 trial in Japanese subjects for lead asset VMX-C001, enabling it to go straight to Phase 3 dev…
#Japan #JP #JapanNews #biotech #drugdevelopment #Japanese #Japanesenews #news #Phase3 #PMDA #VarmXB.V.
https://www.alojapan.com/1377606/varmx-receives-phase-1-waiver-from-japanese-regulator-pmda/